Advertisement

Scientometrics

, Volume 105, Issue 1, pp 485–495 | Cite as

Emerging infectious disease: trends in the literature on SARS and H7N9 influenza

  • Deqiao Tian
  • Tao Zheng
Article

Abstract

Severe acute respiratory syndrome (SARS) and human infection H7N9 influenza are emerging infectious diseases having a relatively high mortality. Epidemics of each began in China. By searching through Science Citation Index, this study analyzed the article literature on SARS and H7N9 influenza, particularly papers in the leading journals The Lancet, New England Journal of Medicine (NEJM), Nature and Science. The results show that the quantity and quality of SARS and H7N9 influenza literature from mainland China changed distinctly over the course of 10 years. Researchers from mainland China published 12 article literature in the The Lancet, NEJM, Nature and Science about H7N9 influenza, whereas mainland China had only 2 article literature about SARS in the same journals. The literature reflects China’s growing strength in the science and technology of emerging infectious disease.

Keywords

Emerging infectious disease Trends Literature SARS H7N9 influenza China 

Notes

Acknowledgments

We thank Elixigen Corporation (Huntington Beach, California, USA) for helping in proofreading and editing the English of final manuscript.

References

  1. Chinese SARS Molecular Epidemiology Consortium. (2004). Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science, 303, 1666–1669.CrossRefGoogle Scholar
  2. Gao, H. N., Lu, H. Z., Cao, B., et al. (2013). Clinical findings in 111 cases of influenza A (H7N9) virus infection. New England Journal of Medicine, 368, 2277–2285.CrossRefGoogle Scholar
  3. Li, W., Shi, Z., Yu, M., et al. (2005). Bats are natural reservoirs of SARS-like coronaviruses. Science, 310(5748), 676–679.CrossRefGoogle Scholar
  4. Li, Q., Zhou, L., Zhou, M., et al. (2014). Epidemiology of human infections with avian influenza A(H7N9) virus in China. New England Journal of Medicine, 370(6), 520–532.CrossRefGoogle Scholar
  5. Liu, D., Shi, W., Shi, Y., et al. (2013). Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet, 381(9881), 1926–1932.CrossRefGoogle Scholar
  6. Marra, M. A., Jones, S. J., Astell, C. R., et al. (2003). The genome sequence of the SARS-associated coronavirus. Science, 300(5624), 1399–1404.CrossRefGoogle Scholar
  7. Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004). The challenge of emerging and re-emerging infectious diseases. Nature, 430(6996), 242–249.CrossRefGoogle Scholar
  8. Rudge, J. W., & Coker, R. (2013). Human to human transmission of H7N9. BMJ, 347, f4730.CrossRefGoogle Scholar
  9. Shi, Y., Zhang, W., Wang, F., et al. (2013). Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science, 342(6155), 243–247.CrossRefGoogle Scholar
  10. Taubenberger, J. K., & Morens, D. M. (2006). 1918 Influenza: The mother of all pandemics. Emerging Infectious Diseases, 12(1), 15–22.CrossRefGoogle Scholar
  11. Tian, D. Q., Yu, Y. Z., Wang, Y. M., & Zheng, T. (2012). Comparison of trends in the quantity and variety of Science Citation Index (SCI) literature on human pathogens between China and the United States. Scientometrics, 93, 1019–1027.CrossRefGoogle Scholar
  12. Wang, Y. (2013). The H7N9 influenza virus in China—Changes since SARS. New England Journal of Medicine, 368(25), 2348–2349.CrossRefGoogle Scholar
  13. WHO. (2003). Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. (Based on data as of the 31 December 2003.) http://www.who.int/csr/sars/country/table2004_04_21/en/.
  14. WHO. (2015). WHO risk assessment of human infection with avian influenza A(H7N9) virus (23 February 2015). http://www.who.int/influenza/human_animal_interface/influenza_h7n9/Risk_Assessment/en/.
  15. Zhou, J., Wang, D., Gao, R., et al. (2013). Biological features of novel avian influenza A (H7N9) virus. Nature, 499(7459), 500–503.CrossRefGoogle Scholar

Copyright information

© Akadémiai Kiadó, Budapest, Hungary 2015

Authors and Affiliations

  1. 1.Beijing Institute of BiotechnologyBeijingPeople’s Republic of China

Personalised recommendations